• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The economic burden of overweight and obesity in Saudi Arabia.沙特阿拉伯超重和肥胖的经济负担。
PLoS One. 2022 Mar 8;17(3):e0264993. doi: 10.1371/journal.pone.0264993. eCollection 2022.
2
The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia.沙特阿拉伯成人和青少年特应性皮炎的人文和经济负担。
J Med Econ. 2022 Jan-Dec;25(1):1231-1239. doi: 10.1080/13696998.2022.2152234.
3
Obesity Burden and Impact of Weight Loss in Saudi Arabia: A Modelling Study.沙特阿拉伯的肥胖负担和减肥影响:一项建模研究。
Adv Ther. 2023 Mar;40(3):1114-1128. doi: 10.1007/s12325-022-02415-8. Epub 2023 Jan 12.
4
Impact of noncommunicable diseases on direct medical costs and worker productivity, Saudi Arabia.非传染性疾病对直接医疗费用和工人生产力的影响,沙特阿拉伯。
East Mediterr Health J. 2022 Apr 28;28(4):296-301. doi: 10.26719/emhj/22.015.
5
The impact of seven major noncommunicable diseases on direct medical costs, absenteeism, and presenteeism in Gulf Cooperation Council countries.七大非传染性疾病对海湾合作委员会国家直接医疗成本、旷工和工作效率低下的影响。
J Med Econ. 2021 Jan-Dec;24(1):828-834. doi: 10.1080/13696998.2021.1945242.
6
Factors of Overweight and Obesity Among Employees of Petrochemical Manufacturing Companies.石化制造企业员工超重和肥胖的因素。
J Community Health. 2023 Jun;48(3):381-389. doi: 10.1007/s10900-022-01177-2. Epub 2022 Dec 12.
7
Epidemiology of obesity and control interventions in Saudi Arabia.沙特阿拉伯肥胖症的流行病学和控制干预措施。
East Mediterr Health J. 2023 Dec 21;29(12):987-994. doi: 10.26719/emhj.23.086.
8
Healthcare Expenditures Associated with Heart Failure in Saudi Arabia: A Cost of Illness Study.沙特阿拉伯与心力衰竭相关的医疗支出:一项疾病成本研究。
Healthcare (Basel). 2021 Aug 4;9(8):988. doi: 10.3390/healthcare9080988.
9
Health and economic burden of insufficient physical activity in Saudi Arabia.沙特阿拉伯体力活动不足的健康和经济负担。
PLoS One. 2024 Apr 10;19(4):e0297278. doi: 10.1371/journal.pone.0297278. eCollection 2024.
10
Health economic burden of COVID-19 in Saudi Arabia.沙特阿拉伯 COVID-19 的健康经济负担。
Front Public Health. 2022 Oct 20;10:927494. doi: 10.3389/fpubh.2022.927494. eCollection 2022.

引用本文的文献

1
Knowledge, Counseling Practice, Perceived Barriers, and Clinical Decision-Making of Community Pharmacists in Saudi Arabia Regarding Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors.沙特阿拉伯社区药剂师在胰高血糖素样肽-1受体激动剂和钠-葡萄糖协同转运蛋白2抑制剂方面的知识、咨询实践、感知障碍及临床决策
Diabetes Metab Syndr Obes. 2025 Aug 30;18:3093-3107. doi: 10.2147/DMSO.S552287. eCollection 2025.
2
Association between pediatric obesity and foot morphology: insights from a large-scale cross-sectional study using photogrammetry.儿童肥胖与足部形态之间的关联:来自一项使用摄影测量法的大规模横断面研究的见解。
BMC Pediatr. 2025 Aug 16;25(1):628. doi: 10.1186/s12887-025-05966-1.
3
Cost-Consequence Analysis of Semaglutide vs. Liraglutide for Managing Obese Prediabetic and Diabetic Patients in Saudi Arabia: A Single-Center Study.司美格鲁肽与利拉鲁肽治疗沙特阿拉伯肥胖糖尿病前期和糖尿病患者的成本-后果分析:一项单中心研究
Healthcare (Basel). 2025 Jul 20;13(14):1755. doi: 10.3390/healthcare13141755.
4
Incidence of Gallstones in Patients with Obesity After Bariatric Surgery in Northern Saudi Arabia: A Cross-Sectional Study.沙特阿拉伯北部肥胖患者减重手术后胆结石的发病率:一项横断面研究
Clin Pract. 2025 Jun 23;15(7):115. doi: 10.3390/clinpract15070115.
5
Advancements and challenges in the management of obesity using pharmacotherapy (Review).药物治疗肥胖症管理的进展与挑战(综述)
Exp Ther Med. 2025 Jun 25;30(2):162. doi: 10.3892/etm.2025.12912. eCollection 2025 Aug.
6
Economic Burden of Obesity in Iran University of Medical Sciences: A Cost Analysis Using the Cost of Illness Framework.伊朗医科大学肥胖症的经济负担:基于疾病成本框架的成本分析
Health Sci Rep. 2025 Jun 30;8(7):e70970. doi: 10.1002/hsr2.70970. eCollection 2025 Jul.
7
Prevalence of obesity and associated risk factors among university students using the newly developed Student Lifestyle and Obesity Risk Questionnaire (SLORQ): a cross-sectional study.使用新开发的《学生生活方式与肥胖风险问卷》(SLORQ)对大学生肥胖及相关风险因素的患病率进行的横断面研究。
PeerJ. 2025 Jun 18;13:e19556. doi: 10.7717/peerj.19556. eCollection 2025.
8
Prevalence, awareness, attitudes, practices, and associated factors of obesity among adults in Makkah, Saudi Arabia.沙特阿拉伯麦加成年人肥胖的患病率、知晓率、态度、行为及相关因素
J Egypt Public Health Assoc. 2025 May 1;100(1):9. doi: 10.1186/s42506-025-00189-9.
9
The Burden of Obesity in Saudi Arabia: A Real-World Cost-of-Illness Study.沙特阿拉伯的肥胖负担:一项真实世界的疾病成本研究。
Clinicoecon Outcomes Res. 2025 Mar 21;17:233-246. doi: 10.2147/CEOR.S504462. eCollection 2025.
10
The Efficacy of Telehealth Versus In-Person Management Delivery in Adult Patients with Obesity.远程医疗与面对面管理服务对成年肥胖患者的疗效比较
Healthcare (Basel). 2024 Nov 4;12(21):2190. doi: 10.3390/healthcare12212190.

本文引用的文献

1
The impact of seven major noncommunicable diseases on direct medical costs, absenteeism, and presenteeism in Gulf Cooperation Council countries.七大非传染性疾病对海湾合作委员会国家直接医疗成本、旷工和工作效率低下的影响。
J Med Econ. 2021 Jan-Dec;24(1):828-834. doi: 10.1080/13696998.2021.1945242.
2
Evaluating Saudi Arabia's 50% carbonated drink excise tax: Changes in prices and volume sales.评估沙特阿拉伯50%的碳酸饮料消费税:价格和销量的变化。
Econ Hum Biol. 2020 Aug;38:100868. doi: 10.1016/j.ehb.2020.100868. Epub 2020 Mar 16.
3
The economic burden of physical inactivity: a global analysis of major non-communicable diseases.体力活动不足的经济负担:主要非传染性疾病的全球分析。
Lancet. 2016 Sep 24;388(10051):1311-24. doi: 10.1016/S0140-6736(16)30383-X. Epub 2016 Jul 28.
4
The costs and consequences of obesity in Germany: a new approach from a prevalence and life-cycle perspective.德国肥胖问题的成本与后果:基于患病率和生命周期视角的新方法。
Eur J Health Econ. 2016 Dec;17(9):1141-1158. doi: 10.1007/s10198-015-0751-4. Epub 2015 Dec 23.
5
The Medical Cost Attributable to Obesity and Overweight in China: Estimation Based on Longitudinal Surveys.中国肥胖和超重所致医疗费用:基于纵向调查的估计
Health Econ. 2016 Oct;25(10):1291-311. doi: 10.1002/hec.3217. Epub 2015 Jul 30.
6
Direct healthcare cost of obesity in brazil: an application of the cost-of-illness method from the perspective of the public health system in 2011.巴西肥胖症的直接医疗成本:2011年从公共卫生系统角度应用疾病成本法
PLoS One. 2015 Apr 1;10(4):e0121160. doi: 10.1371/journal.pone.0121160. eCollection 2015.
7
Health care costs attributable to overweight calculated in a standardized way for three European countries.以标准化方式计算的三个欧洲国家超重所致的医疗保健费用。
Eur J Health Econ. 2016 Jan;17(1):61-9. doi: 10.1007/s10198-014-0655-8. Epub 2014 Nov 29.
8
Health burden and costs of obesity and overweight in Germany: an update.德国肥胖与超重的健康负担及成本:最新情况
Eur J Health Econ. 2015 Dec;16(9):957-67. doi: 10.1007/s10198-014-0645-x. Epub 2014 Nov 8.
9
Direct medical cost and glycemic control in type 2 diabetic Saudi patients.2 型糖尿病沙特患者的直接医疗费用与血糖控制。
Appl Health Econ Health Policy. 2013 Dec;11(6):671-5. doi: 10.1007/s40258-013-0065-6.
10
Annual medical spending attributable to obesity: payer-and service-specific estimates.肥胖导致的年度医疗支出:按支付方和服务划分的估计。
Health Aff (Millwood). 2009 Sep-Oct;28(5):w822-31. doi: 10.1377/hlthaff.28.5.w822. Epub 2009 Jul 27.

沙特阿拉伯超重和肥胖的经济负担。

The economic burden of overweight and obesity in Saudi Arabia.

机构信息

World Bank Group Consultant, Colorado Springs, Colo., United States of America.

Sol Price School of Public Policy, University of Southern California, Los Angeles, Calif., United States of America.

出版信息

PLoS One. 2022 Mar 8;17(3):e0264993. doi: 10.1371/journal.pone.0264993. eCollection 2022.

DOI:10.1371/journal.pone.0264993
PMID:35259190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8903282/
Abstract

CONTEXT

The prevalence of overweight and obesity in Saudi Arabia has been rising. Although the health burden of excess weight is well established, little is known about the economic burden.

AIMS

To assess the economic burden-both direct medical costs and the value of absenteeism and presenteeism-resulting from overweight and obesity in Saudi Arabia.

SETTINGS AND DESIGN

The cost of overweight and obesity in Saudi Arabia was estimated from a societal perspective using an epidemiologic approach.

METHODS AND MATERIALS

Data were obtained from previously published studies and secondary databases.

STATISTICAL ANALYSIS USED

Overweight/obesity-attributable costs were calculated for six major noncommunicable diseases; sensitivity analyses were conducted for key model parameters.

RESULTS

The impact of overweight and obesity for these diseases is found to directly cost a total of $3.8 billion, equal to 4.3 percent of total health expenditures in Saudi Arabia in 2019. Estimated overweight and obesity-attributable absenteeism and presenteeism costs a total of $15.5 billion, equal to 0.9 percent of GDP in 2019.

CONCLUSIONS

Even when limited to six diseases and a subset of total indirect costs, results indicate that overweight and obesity are a significant economic burden in Saudi Arabia. Future studies should identify strategies to reduce the health and economic burden resulting from excess weight in Saudi Arabia.

摘要

背景

超重和肥胖在沙特阿拉伯的流行率一直在上升。尽管超重对健康的负担已经得到充分证实,但对其经济负担知之甚少。

目的

评估超重和肥胖给沙特阿拉伯带来的经济负担——包括直接医疗费用以及旷工和出勤的价值损失。

设置和设计

采用流行病学方法,从社会角度评估沙特超重和肥胖的经济负担。

方法和材料

数据来自先前发表的研究和二手数据库。

使用的统计分析

计算了六种主要非传染性疾病中与超重/肥胖相关的成本;对关键模型参数进行了敏感性分析。

结果

超重和肥胖对这些疾病的影响直接导致总花费 38 亿美元,相当于 2019 年沙特阿拉伯总卫生支出的 4.3%。估计超重和肥胖导致的旷工和出勤价值损失总计 155 亿美元,相当于 2019 年 GDP 的 0.9%。

结论

即使仅考虑六种疾病和总间接成本的一部分,结果表明超重和肥胖是沙特阿拉伯的重大经济负担。未来的研究应确定减少超重对沙特阿拉伯健康和经济负担的策略。